Option Care Health, Inc.

BrightSpring Health Services, Inc.

UnitedHealth Group Incorporated

Barron's <a href="https://www.barrons.com/articles/buy-option-care-health-stock-price-pick-1e20146a?mod=hp_STOCKPICKS_1">says</a>&nbsp;that shares of Option Care Health, a small company that provides home infusion services, offer a combination of solid growth tailwinds and compelling value that deserves a closer look. The stock price fell last year, but now there is room for a rebound as demand for at-home and alternate site medical services rises.

Barron's thinks infusion therapy leader Option Care is undervalued, says 'buy'


The long-expected cut helped propel the Russell 2000 higher, even as the broader market finished the day lower

'Fragile rally': Russell 2000 falls short of all-time high after Fed rate cut

Krispy Kreme, Inc.

ON Semiconductor Corporation

FBI Director Kash Patel spurred a rally in Krispy Kreme shares yesterday, September 17,&nbsp;after he said they were a solid investment and that he had invested tens of thousands of dollars in the stock. Krispy Kreme ended the day with a 12% gain.

FBI Director Patel calls Krispy Kreme stock a 'buy' and sets off a rally


Altimmune, Inc.

Terns Pharmaceuticals, Inc.

Viking Therapeutics, Inc.

Following the meteoric success of Novo Nordisk and Eli Lilly’s semaglutide-based weight-loss injections, the obesity and metabolic disease treatment sector has drawn heightened investor attention. Since Ozempic was <a href="https://www.prnewswire.com/news-releases/novo-nordisk-receives-fda-approval-of-ozempic-semaglutide-injection-for-the-treatment-of-adults-with-type-2-diabetes-300567052.html">approved</a>&nbsp;in December 2017, Novo Nordisk’s stock has gained 125%, pushing its <a href="https://companiesmarketcap.com/novo-nordisk/marketcap/">market capitalization</a> to $252 billion. Eli Lilly, after launching <a href="https://investor.lilly.com/news-releases/news-release-details/fda-approves-lillys-Zepboundtm-tirzepatide-chronic-weight">Zepbound</a>&nbsp;in November 2023, has seen its share price climb 23% and its <a href="https://companiesmarketcap.com/eli-lilly/marketcap/">market cap</a> reach $681 billion. Morgan Stanley <a href="https://www.morganstanley.com/insights/articles/weight-loss-medication-market-unstoppable-growth#:~:text=Morgan%2520Stanley%2520Research%2520now%2520estimates,about%2520%252415%2520billion%2520in%2520sales">estimates</a>&nbsp;the global market for obesity drugs could exceed $150 billion by 2035.

Small caps that can challenge Novo Nordisk and Eli Lilly in the obesity drug market

Toll Brothers, Inc.

Beazer Homes USA, Inc.

KB Home

Barron's has <a href="https://www.barrons.com/articles/stocks-small-caps-fed-rate-cut-295f287b?mod=RTA">named</a> eight small-cap stocks that are set to "pop"&nbsp;on the Fed decision today, when it's "almost a given" that the&nbsp;Fed will cut rates&nbsp;by 25 basis points. Small caps have&nbsp;lesser ability to navigate treacherous economic and financial conditions, meaning their stock prices have more to lose on the downside and more to gain on the upside. Barron's looked for names that have gained even more than the Russell 2000 since August 1, are in economically sensitive sectors (e.g., communications, commodities, oil and gas, tech, and industrial), and have climbed more on the back of economic expectations and less on their own earnings reports.

Barron's picks eight small caps set to 'pop' on Fed rate cut

Joby Aviation, Inc.

Archer Aviation Inc.

Shares of air taxi developer Joby Aviation may be poised for sharp, speculative gains, according to Freedom Broker. Last week, the U.S. government <a href="https://www.claimsjournal.com/news/national/2025/09/15/332956.htm">announced</a>&nbsp;an eVTOL pilot program in which Joby is expected to participate. Earlier, the company also agreed to <a href="https://ir.jobyaviation.com/news-events/press-releases/detail/143/joby-to-bring-blades-air-mobility-services-to-the-uber">expand</a>&nbsp;its partnership with Uber. Freedom Broker analysts believe these factors could drive the stock higher.

Freedom Broker sees 18% short-term upside in air taxi developer Joby Aviation 

WEBTOON Entertainment Inc.

The Walt Disney Company

The company's market value jumped nearly 40% in a day

Webtoon soars on deal to create digital comics platform for Disney brands

California Resources Corporation

Berry Corporation

Investors may want to take advantage of&nbsp;easing environmental rules for drilling in California by buying shares of small-cap oil producer California Resources, several Wall Street analysts have <a href="https://www.barrons.com/articles/california-oil-regulation-kern-berry-acecb7dc?mod=hp_WIND_A_3_3#:~:text=%D0%98%D0%BD%D0%B2%D0%B5%D1%81%D1%82%D0%BE%D1%80%D0%B0%D0%BC%2C%20%D0%B6%D0%B5%D0%BB%D0%B0%D1%8E%D1%89%D0%B8%D0%BC%20%D1%81%D1%8B%D0%B3%D1%80%D0%B0%D1%82%D1%8C,%D0%BF%D1%80%D0%BE%D1%82%D0%B8%D0%B2%20%D0%BD%D0%B5%D0%B4%D0%B0%D0%B2%D0%BD%D0%B8%D1%85%20%2456.">flagged</a>. Yesterday, September 15, the company <a href="https://www.crc.com/news-releases/news-release-details/california-resources-corporation-announces-all-stock-combination">announced</a>&nbsp;it would buy smaller peer Berry Corporation.&nbsp;

Analysts recommend oil producer California Resources amid acquisition of smaller peer

Corcept Therapeutics Incorporated

LTC Properties, Inc.

Goosehead Insurance, Inc

MarketWatch has <a href="https://www.marketwatch.com/story/11-fast-growing-small-cap-stocks-that-could-get-a-boost-from-the-feds-next-move-424328aa">compiled</a>&nbsp;a list of 11 fast-growing small-cap stocks from the S&amp;P SmallCap 600 that could get a boost from the Fed’s next move. Wall Street forecasts that their earnings will continue to rise at least through 2027, a pace three times faster than the average for index companies.

MarketWatch names 11 fast-growing small caps set to outperform amid Fed rate cuts

Lottery.com Inc.

Noble Capital Markets sees the fair value of SEGG Media, the media platform that owns Sports.com, Concerts.com, and Lottery.com, at $20 per share, according to a coverage initiation <a href="https://www.channelchek.com/news-channel/segg-media-corporation-segg-leveraging-strong-brands-as-a-foundation-for-growth">report</a>. This target price is more than 3.5 times the <a href="https://finance.yahoo.com/quote/SEGG/">current share price</a>. Analysts believe that under a new management, the company created after the collapse of Lottery.com has every chance to get back to growth.

Noble initiates coverage of micro-cap media stock SEGG Media with 'buy', 277% upside

The Russell 2000 index, which tracks small- and mid-cap stocks, has <a href="https://finance.yahoo.com/quote/%5ERUT/">risen</a>&nbsp;5% over the last month and could soon <a href="https://www.barrons.com/articles/small-cap-stocks-rally-russell-2000-88aac4b9?refsec=small-caps&amp;mod=topics_small-caps">surpass</a>&nbsp;its 2021 record. Some Wall Street strategists <a href="https://www.bloomberg.com/news/articles/2025-09-12/wall-street-expects-rally-in-riskiest-stocks-to-last-12-months?embedded-checkout=true">believe</a>&nbsp;the rally is just beginning, while others <a href="https://www.barrons.com/articles/small-cap-stocks-rally-russell-2000-88aac4b9?refsec=small-caps&amp;mod=topics_small-caps">argue</a>&nbsp;these companies may struggle to sustain momentum amid a sluggish economy.

Russell 2000 nears record high: How long can the small-cap rally last?

Riot Platforms, Inc.

Illumina, Inc.

Teradyne, Inc.

Oklo Inc.

A recent Freedom Capital strategic outlook highlights small- and mid-cap opportunities across innovation economy sectors

Wellness, robots, biotech: Freedom names smid beneficiaries of innovation trends

MAIA Biotechnology, Inc.

Shares of micro cap MAIA Biotechnology <a href="https://finance.yahoo.com/quote/MAIA/">jumped</a>&nbsp;almost 9% yesterday, September 11, to end the day at $1.70 per share, an almost two-month high The gain followed the company's&nbsp;<a href="https://ir.maiabiotech.com/news-events/press-releases/detail/150/maia-biotechnology-highlights-positive-efficacy-data-from">announcement</a>&nbsp;that its experimental therapy for lung cancer, which is in the middle of phase II clinical trials, has demonstrated double the efficacy of standard treatment.

MAIA Biotechnology shares jump 9% on upbeat latest lung cancer therapy trial results

Legence Corp

Legence adds its name to the string of companies going public amid heightened investor enthusiasm

Legence IPO: Blackstone-backed engineering firm raises $728 million in Nasdaq IPO

Black Rock Coffee Bar

The Arizona-based chain raised $294.1 million in its IPO

Black Rock Coffee Bar IPO: Shares of drive-through-focused coffee chain debut

Tesla, Inc.

If future competition limits Tesla's profits, it's possible the stock could fall below its current target, Goldman Sachs believes

Tesla shares have broken off a seven-day rally. Goldman believes that there is now nowhere to go higher

NIKE, Inc.

Nike's stock has lagged the overall market badly this year: it's down 5 percent

RBC advised buying Nike shares. Why does he expect them to grow by another quarter?

Novo Nordisk A/S

Eli Lilly and Company

Novo Nordisk's Ozempic has shown to reduce the risk of heart attack, stroke and death in patients with diabetes and cardiovascular disease

Novo drug outperformed its Eli Lilly counterpart in trials. Time to buy stock?

Intel Corporation

NVIDIA Corporation

Palantir Technologies Inc.

Three major U.S. stock indices hit records in trading on September 18, a day after the U.S. Federal Reserve <a href="https://oninvest.com/article/frs-ssa-vpervye-v-2025-godu-snizila-stavku-cto-budet-s-akciami">cut</a> interest rates for the first time this year. Investors were buoyed on Thursday by a deal between Nvidia and Intel, under the terms of which the former <a href="https://oninvest.com/article/nvidia-investiruet-v-intel-5-mlrd-v-ramkah-ii-sotrudnicestva-akcii-intel-vzleteli">will invest</a> $5 billion in the latter.

Nvidia and Intel deal supports tech sector: three major US indices hit new records

Berkshire Hathaway's $1.6 billion investment has spurred a surge in interest in the securities of the largest insurer

Another analyst believed in UnitedHealth after Buffett's deal and the Fed rate cut

Latest Small Caps Stock News and Analysis